Simple Sleep Health Management for Cardiology


Sleep apnea is a serious, potentially life-threatening sleep-related breathing disorder that is often linked with loud, heavy snorers.

The more common form of sleep apnea is triggered by an obstruction in the upper airway (OSA - Obstructive Sleep Apnea), which decreases the amount of inhaled air, collapsing the tissue in the back of the throat, and disrupting sleep. People with OSA snore and repeatedly experience brief interruptions of breathing (apnea) during sleep. This may occur hundreds of times during sleep, which deprives the brain and other vital organs of life-sustaining oxygen.

There is a clear link between sleep apnea and cardiovascular problems. It’s possible that the constant fluctuation in blood oxygen levels caused by sleep apnea may contribute to arterial inflammation, blood flow obstruction, insulin resistance, and, increased hypertension and cardiovascular-related events.

~25% of adult population(1,2,3)

60 million Americans suffer from OSA

~40 million undiagnosed!(4)
(1) data source (2) data source (3) data source (4)data source

Sleep apnea is a major comorbidity to most cardiac diseases:



People with Obstructive Sleep Apnea (OSA) are:

almost
x2likely to die

from sudden cardiac death
(1) data source.
A study in The Lancet, reported that the risk of a cardiovascular event was three times higher in men with severe apnea. A person with severe sleep apnea can momentarily stop breathing hundreds of times a night. These pauses in breathing can cause drastic changes in oxygen levels, putting an enormous strain on the heart that can lead to an increase in heart rate and risk for vascular disease.
Sleep apnea can also contribute to memory problems and problems at work and automobile/truck-related accidents due to fatigue. Researchers have also linked sleep apnea to erectile dysfunction and obesity, triggered in great part by the disturbed sleep states caused by sleep apnea.
OSA and AFib (Atrial Fibrillation)

Sleep Apnea is a common co-morbidity to AFib (Atrial Fibrilation), affecting approx.60 million patients in the USA alone. Clinical data has shown the risk of AFib recurrence after ablation can increase by 57% when OSA patients do not undergo therapy. Management of AFib patients with OSA can improve outcomes and patient care.

49% of Atrial Fibrillation patients(1)

24% in the general population(2,3,4)

80% of apnea sufferers - undiagnosed
(1)data source. (2)data source. (3) data source. (4) data source.

For clinical data on the link between OSA and Afib click here

Used by over 1 million patients worldwide

Why is WatchPAT ideal for cardiologists?

  • Enables the Cardiologists to expand their service portfolio to include the identification of OSA and manage their patient’s complete pathway
  • A new source of revenue - enables larger volumes of testing and OSA management, reduces referral needs and enables clinics to offer such services without the need of additional investment
  • Measures a vascular signal (vs. respiratory) – speaks the ‘language of cardiology
  • WatchPAT can be implemented with the Total Sleep Solution - a customizable business model click here
  • Innovative PAT® technology, clinically proven to have 90% correlation to the gold standard Sleep Lab (PSG) test
  • WatchPAT combines the simplicity of pulse oximetry together with the accuracy of PSG and the cost-effectiveness of a Home Sleep Test (HST)